Current and emerging monoclonal antibodies for treating familial hypercholesterolemia in children
{{output}}
Introduction: Heterozygous familial hypercholesterolemia (HeFH) is a common genetic disorder caused by pathogenic variants in the LDL-C metabolism. Lifelong exposure to elevated LDL-C levels leads to a high risk of premature card... ...
